Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00397033
What this trial is testing

Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.

Who this might be right for
Schizoaffective DisorderPsychotic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 316
Post-approval studies (Phase 4)Study completedNCT01685931
What this trial is testing

Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics

Who this might be right for
Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 617
Not applicableStudy completedNCT05130853
What this trial is testing

Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective Disorder
University of Campania Luigi Vanvitelli 48
Large-scale testing (Phase 3)Study completedNCT02983188
What this trial is testing

Berberine as Adjuvant Treatment for Schizophrenia Patients

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersMetabolic Syndrome x
The University of Hong Kong 113
Not applicableStudy completedNCT03621540
What this trial is testing

Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizophrenia

Who this might be right for
SchizophreniaCognitive Deficits
University Hospital Tuebingen 37
Not applicableEnded earlyNCT03261817
What this trial is testing

A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders

Who this might be right for
SchizophreniaPhysical ActivitySchizo Affective Disorder
University Hospital, Caen 62
Post-approval studies (Phase 4)Study completedNCT00167817
What this trial is testing

Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study

Who this might be right for
Schizophrenia
Veterans Medical Research Foundation 15
Early research (Phase 1)Study completedNCT06253546
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Teva Branded Pharmaceutical Products R&D LLC 24
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Post-approval studies (Phase 4)Study completedNCT00761670
What this trial is testing

Efficacy Study on Cognitive Functions in Schizophrenic Patients

Who this might be right for
Schizophrenia
Sanofi 37
Large-scale testing (Phase 3)Looking for participantsNCT07184619
What this trial is testing

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Who this might be right for
Treatment-resistant Schizophrenia
Newron Pharmaceuticals SPA 400
Post-approval studies (Phase 4)Study completedNCT00290121
What this trial is testing

Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

Who this might be right for
Schizophrenia
Université de Montréal 25
Early research (Phase 1)Study completedNCT01892384
What this trial is testing

Safety and Tolerability of BI 409306 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 40
Post-approval studies (Phase 4)Study completedNCT01811160
What this trial is testing

Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics

Who this might be right for
Second Generation Antipsychotic Induced Metabolic Adverse Effects
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente 50
Post-approval studies (Phase 4)Study completedNCT00486005
What this trial is testing

Weight Gain Management in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 74
Early research (Phase 1)Study completedNCT02769936
What this trial is testing

Glutamate, Learning, and Working Memory

Who this might be right for
Schizophrenia
University of California, Los Angeles 110
Not applicableUnknownNCT02873884
What this trial is testing

Impact of Case-management on Therapeutic Alliance With First Episode Psychosis Patients (CAMAT)

Who this might be right for
Psychotic Disorders
University Hospital, Caen 30
Not applicableActive Not RecruitingNCT06304233
What this trial is testing

The Protein Disrupted in Schizophrenia 1 (DISC1) as a Novel Biomarker for Cardiac Disease

Who this might be right for
Heart DiseasesHeart; Functional DisturbanceSchizophrenia
Norwegian University of Science and Technology 120
Early research (Phase 1)Study completedNCT06880328
What this trial is testing

18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)Study completedNCT00528905
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 400
Next Page